vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and New Fortress Energy Inc. (NFE). Click either name above to swap in a different company.

New Fortress Energy Inc. is the larger business by last-quarter revenue ($326.2M vs $270.8M, roughly 1.2× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -259.7%, a 260.4% gap on every dollar of revenue. On growth, New Fortress Energy Inc. posted the faster year-over-year revenue change (-7.0% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-134.8M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

New Fortress Energy Inc. is a global energy infrastructure firm developing, owning and operating LNG import/export terminals, natural gas supply networks and low-carbon projects. It serves utility, industrial and public sector clients across the Americas and Caribbean, delivering affordable, lower-emission energy resources.

HCM vs NFE — Head-to-Head

Bigger by revenue
NFE
NFE
1.2× larger
NFE
$326.2M
$270.8M
HCM
Growing faster (revenue YoY)
NFE
NFE
+9.6% gap
NFE
-7.0%
-16.5%
HCM
Higher net margin
HCM
HCM
260.4% more per $
HCM
0.7%
-259.7%
NFE
More free cash flow
HCM
HCM
$138.1M more FCF
HCM
$3.4M
$-134.8M
NFE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
NFE
NFE
Revenue
$270.8M
$326.2M
Net Profit
$2.0M
$-847.1M
Gross Margin
37.7%
35.5%
Operating Margin
-13.2%
-193.0%
Net Margin
0.7%
-259.7%
Revenue YoY
-16.5%
-7.0%
Net Profit YoY
-83.6%
-277.4%
EPS (diluted)
$0.00
$-3.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
NFE
NFE
Q4 25
$270.8M
$326.2M
Q3 25
$240.3M
Q2 25
$277.7M
$228.1M
Q1 25
$324.5M
$384.9M
Q4 24
$350.7M
Q3 24
$446.0M
Q2 24
$305.7M
$291.2M
Q1 24
$609.5M
Net Profit
HCM
HCM
NFE
NFE
Q4 25
$2.0M
$-847.1M
Q3 25
$-263.0M
Q2 25
$455.0M
$-546.5M
Q1 25
$11.9M
$-175.4M
Q4 24
$-224.4M
Q3 24
$9.3M
Q2 24
$25.8M
$-88.9M
Q1 24
$54.1M
Gross Margin
HCM
HCM
NFE
NFE
Q4 25
37.7%
35.5%
Q3 25
18.1%
Q2 25
0.1%
8.4%
Q1 25
48.0%
21.4%
Q4 24
17.6%
Q3 24
27.1%
Q2 24
41.1%
23.8%
Q1 24
62.4%
Operating Margin
HCM
HCM
NFE
NFE
Q4 25
-13.2%
-193.0%
Q3 25
-37.4%
Q2 25
-1.3%
-170.3%
Q1 25
-5.0%
-3.3%
Q4 24
65.0%
Q3 24
17.8%
Q2 24
-9.0%
12.3%
Q1 24
30.4%
Net Margin
HCM
HCM
NFE
NFE
Q4 25
0.7%
-259.7%
Q3 25
-109.4%
Q2 25
163.8%
-239.6%
Q1 25
3.7%
-45.6%
Q4 24
-64.0%
Q3 24
2.1%
Q2 24
8.4%
-30.5%
Q1 24
8.9%
EPS (diluted)
HCM
HCM
NFE
NFE
Q4 25
$0.00
$-3.03
Q3 25
$-0.96
Q2 25
$0.52
$-1.99
Q1 25
$0.01
$-0.65
Q4 24
$-1.10
Q3 24
$0.03
Q2 24
$0.03
$-0.42
Q1 24
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
NFE
NFE
Cash + ST InvestmentsLiquidity on hand
$1.4B
$226.5M
Total DebtLower is stronger
$93.2M
$8.2B
Stockholders' EquityBook value
$1.2B
$182.6M
Total Assets
$1.8B
$10.6B
Debt / EquityLower = less leverage
0.08×
44.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
NFE
NFE
Q4 25
$1.4B
$226.5M
Q3 25
$145.2M
Q2 25
$1.4B
$551.1M
Q1 25
$836.1M
$447.9M
Q4 24
$492.9M
Q3 24
$90.8M
Q2 24
$802.5M
$133.0M
Q1 24
$143.5M
Total Debt
HCM
HCM
NFE
NFE
Q4 25
$93.2M
$8.2B
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
$8.9B
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
NFE
NFE
Q4 25
$1.2B
$182.6M
Q3 25
$1.1B
Q2 25
$1.2B
$1.3B
Q1 25
$759.9M
$1.8B
Q4 24
$1.9B
Q3 24
$1.6B
Q2 24
$740.1M
$1.6B
Q1 24
$1.7B
Total Assets
HCM
HCM
NFE
NFE
Q4 25
$1.8B
$10.6B
Q3 25
$12.0B
Q2 25
$1.8B
$12.0B
Q1 25
$1.3B
$13.1B
Q4 24
$12.9B
Q3 24
$12.0B
Q2 24
$1.3B
$11.4B
Q1 24
$10.9B
Debt / Equity
HCM
HCM
NFE
NFE
Q4 25
0.08×
44.78×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
4.74×
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
NFE
NFE
Operating Cash FlowLast quarter
$8.2M
$-76.2M
Free Cash FlowOCF − Capex
$3.4M
$-134.8M
FCF MarginFCF / Revenue
1.2%
-41.3%
Capex IntensityCapex / Revenue
1.8%
18.0%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$-1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
NFE
NFE
Q4 25
$8.2M
$-76.2M
Q3 25
$-171.0M
Q2 25
$-72.9M
$-329.0M
Q1 25
$40.3M
$-7.2M
Q4 24
$445.3M
Q3 24
$-20.0M
Q2 24
$-39.8M
$113.9M
Q1 24
$63.0M
Free Cash Flow
HCM
HCM
NFE
NFE
Q4 25
$3.4M
$-134.8M
Q3 25
$-231.6M
Q2 25
$-82.2M
$-726.7M
Q1 25
$32.5M
$-262.3M
Q4 24
$-210.3M
Q3 24
$-367.0M
Q2 24
$-49.9M
$-493.2M
Q1 24
$-457.9M
FCF Margin
HCM
HCM
NFE
NFE
Q4 25
1.2%
-41.3%
Q3 25
-96.4%
Q2 25
-29.6%
-318.6%
Q1 25
10.0%
-68.2%
Q4 24
-60.0%
Q3 24
-82.3%
Q2 24
-16.3%
-169.3%
Q1 24
-75.1%
Capex Intensity
HCM
HCM
NFE
NFE
Q4 25
1.8%
18.0%
Q3 25
25.2%
Q2 25
3.3%
174.4%
Q1 25
2.4%
66.3%
Q4 24
187.0%
Q3 24
77.8%
Q2 24
3.3%
208.4%
Q1 24
85.5%
Cash Conversion
HCM
HCM
NFE
NFE
Q4 25
4.21×
Q3 25
Q2 25
-0.16×
Q1 25
3.38×
Q4 24
Q3 24
-2.15×
Q2 24
-1.54×
Q1 24
1.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons